and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Affimed N.V. Stock Price (Quote) NASDAQ:AFMD
$3.00 ( 6.76% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.23 | $3.18 | Tuesday, 5th Jul 2022 AFMD stock ended at $3.00. This is 6.76% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 10.18% from a day low at $2.75 to a day high of $3.03. |
| 90 days | $2.23 | $5.10 | |
| 52 weeks | $2.23 | $7.39 |
Historical Affimed N.V. prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $2.76 | $3.03 | $2.75 | $3.00 | 1 229 870 |
| 2022-07-01 | $2.79 | $2.86 | $2.73 | $2.81 | 421 295 |
| 2022-06-30 | $2.75 | $2.80 | $2.70 | $2.77 | 653 948 |
| 2022-06-29 | $2.78 | $2.82 | $2.70 | $2.81 | 600 771 |
| 2022-06-28 | $2.96 | $2.96 | $2.75 | $2.78 | 1 208 236 |
| 2022-06-27 | $2.71 | $2.98 | $2.71 | $2.92 | 1 253 905 |
| 2022-06-24 | $2.77 | $2.87 | $2.71 | $2.71 | 5 447 585 |
| 2022-06-23 | $2.76 | $2.85 | $2.70 | $2.84 | 1 099 130 |
| 2022-06-22 | $2.50 | $2.80 | $2.46 | $2.73 | 1 098 014 |
| 2022-06-21 | $2.55 | $2.66 | $2.54 | $2.56 | 1 027 597 |
| 2022-06-17 | $2.34 | $2.60 | $2.34 | $2.48 | 1 232 151 |
| 2022-06-16 | $2.32 | $2.35 | $2.23 | $2.32 | 728 336 |
| 2022-06-15 | $2.32 | $2.45 | $2.26 | $2.37 | 1 483 957 |
| 2022-06-14 | $2.37 | $2.41 | $2.25 | $2.27 | 790 632 |
| 2022-06-13 | $2.47 | $2.50 | $2.34 | $2.37 | 981 875 |
| 2022-06-10 | $2.68 | $2.68 | $2.55 | $2.60 | 1 241 368 |
| 2022-06-09 | $2.89 | $3.00 | $2.73 | $2.74 | 648 110 |
| 2022-06-08 | $2.94 | $3.07 | $2.88 | $2.92 | 1 142 460 |
| 2022-06-07 | $2.77 | $2.98 | $2.77 | $2.96 | 983 091 |
| 2022-06-06 | $3.13 | $3.18 | $2.79 | $2.82 | 1 502 194 |
| 2022-06-03 | $3.11 | $3.24 | $3.04 | $3.10 | 1 104 150 |
| 2022-06-02 | $3.12 | $3.19 | $3.07 | $3.10 | 1 203 895 |
| 2022-06-01 | $3.11 | $3.21 | $2.92 | $3.13 | 1 571 709 |
| 2022-05-31 | $3.31 | $3.31 | $3.04 | $3.10 | 949 557 |
| 2022-05-27 | $3.15 | $3.25 | $3.06 | $3.20 | 1 233 528 |
| 2022-05-26 | $3.18 | $3.28 | $3.14 | $3.15 | 1 138 296 |
| 2022-05-25 | $3.13 | $3.20 | $3.08 | $3.17 | 708 599 |
| 2022-05-24 | $3.22 | $3.24 | $3.09 | $3.12 | 905 493 |
| 2022-05-23 | $3.32 | $3.40 | $3.25 | $3.27 | 1 075 956 |
| 2022-05-20 | $3.45 | $3.53 | $3.15 | $3.28 | 1 854 526 |
| 2022-05-19 | $3.24 | $3.45 | $3.22 | $3.40 | 2 468 196 |
| 2022-05-18 | $3.41 | $3.51 | $3.20 | $3.26 | 1 860 769 |
| 2022-05-17 | $3.37 | $3.52 | $3.34 | $3.51 | 734 036 |
| 2022-05-16 | $3.24 | $3.41 | $3.22 | $3.28 | 866 177 |
| 2022-05-13 | $3.13 | $3.32 | $3.13 | $3.27 | 1 861 769 |
| 2022-05-12 | $2.88 | $3.17 | $2.88 | $3.07 | 2 653 733 |
| 2022-05-11 | $3.21 | $3.28 | $2.92 | $2.93 | 2 116 501 |
| 2022-05-10 | $3.16 | $3.34 | $3.11 | $3.24 | 1 760 437 |
| 2022-05-09 | $3.38 | $3.42 | $2.99 | $3.04 | 3 439 945 |
| 2022-05-06 | $3.74 | $3.77 | $3.39 | $3.42 | 1 752 233 |
| 2022-05-05 | $3.95 | $3.96 | $3.68 | $3.78 | 1 279 311 |
| 2022-05-04 | $3.89 | $4.00 | $3.71 | $3.99 | 1 312 606 |
| 2022-05-03 | $3.98 | $4.01 | $3.83 | $3.91 | 1 276 520 |
| 2022-05-02 | $3.77 | $3.95 | $3.74 | $3.95 | 1 140 545 |
| 2022-04-29 | $3.75 | $3.91 | $3.74 | $3.76 | 1 028 242 |
| 2022-04-28 | $3.81 | $3.83 | $3.62 | $3.80 | 1 513 431 |
| 2022-04-27 | $3.80 | $3.92 | $3.77 | $3.79 | 1 334 471 |
| 2022-04-26 | $4.00 | $4.08 | $3.82 | $3.85 | 1 889 171 |
| 2022-04-25 | $3.97 | $4.06 | $3.81 | $4.06 | 2 498 631 |
| 2022-04-22 | $3.95 | $3.97 | $3.85 | $3.89 | 1 480 000 |
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies. Its lead candidate is AFM13, a natural killer cell TandAb designed for the treatment of CD30-positive (CD30+) B- and T-cell malignancies, including Hodgkin lymphoma. The companys product candidates also include AFM11, a T-cell TandAb, which is in Phase I clinical trial for the treatment of various CD19+ B-cell malignancies, in... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
